Which Analgesia is Better for Proximal Femoral Fractures?
- Efficacy of Combined Lateral Femoral Cutaneous Nerve Block With Pericapsular Nerve Group Block Versus Fascia Iliaca Block in Proximal Femoral Fractures
1 other identifier
interventional
100
1 country
1
Brief Summary
This patient population is typically elderly and frail. They are at risk of adverse effects secondary to inadequate pain management such as prolonged admissions and poor functional outcomes. Regional analgesia is preferred due to their opioid-sparing effects and reduction in related adverse effects but The analgesia from these blocks is only moderate and literature suggests that the obturator nerve (ON) is not covered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2020
CompletedFirst Posted
Study publicly available on registry
March 16, 2020
CompletedStudy Start
First participant enrolled
September 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedSeptember 23, 2020
September 1, 2020
8 months
March 12, 2020
September 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Time of performance of Spinal Anesthesia
Is defined as the time measured from the start of positioning to the completion of the intrathecal bupivacaine injection
just before surgery.
Secondary Outcomes (18)
Pain measurement at rest
immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Pain measurement on movement
immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
Pain measurement during positioning for spinal anesthesia
Just before surgery
The severity of postoperative pain at rest
immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
The severity of postoperative pain on movement
immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.
- +13 more secondary outcomes
Study Arms (2)
Fascia iliaca block
ACTIVE COMPARATORPatients will receive Fascia iliaca block
combined LFCN block with PENG block
ACTIVE COMPARATORPatients will receive a combined lateral femoral cutaneous nerve block with pericapsular nerve group block
Interventions
A linear probe will be placed in the sagittal plane to the inguinal ligament to obtain an image of "bow-tie sign" formed by the muscle fascias, a spinal needle will be inserted 1 cm cephalad Using an in-plane approach, the fascia iliaca is penetrated, 30 mL of bupivacaine 0.25% before spinal anesthesia.
With the patient supine, the linear probe is placed parallel to the inguinal ligament. LFCN appear as a hypoechoic oval structure between the tensor fascia lata and Sartorius muscles. The needle is inserted in plane. 5 mL of LA is injected. The PENG block will be performed in the supine position. A curvilinear probe will be placed transversely over the anterior inferior iliac spine and then rotated counterclockwise 45 degrees. the ilio pubic eminence, the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle will be observed. A spinal needle will be inserted in plane to the plane between the psoas tendon and the pubic ramus. 25 mL of bupivacaine 0.25% will be injected
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status I, II and III.
You may not qualify if:
- Patient refusal.
- Neuromuscular diseases
- Hematological diseases
- Bleeding abnormality
- Coagulation abnormality.
- Psychiatric diseases.
- Local skin infection at the site of the block.
- Local skin sepsis at the site of the block
- Known intolerance to the study drugs.
- Body Mass Index \> 40 Kg/m2.
- Multiple trauma patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University, emergency hospital
Al Mansurah, DK, 050, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mona A Hasheesh, MD
Professor of Anesthesia and Surgical Intensive care,,P
- STUDY DIRECTOR
Eiad A Ramzy, MD
Associate Professor of Anesthesia and Surgical Intensive care,
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single-blind study
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2020
First Posted
March 16, 2020
Study Start
September 21, 2020
Primary Completion
June 1, 2021
Study Completion
March 1, 2022
Last Updated
September 23, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- after completing the study and being accepted for publication.
- Access Criteria
- The data will be accessible to the investigators and PRS administrators with hiding the identifiers for the patients
Yes, Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR)